Safety Evaluation of Adverse Reactions in Diabetes

Summary

The purpose of this study is to assess the effects of incretin-based antidiabetic therapies (DPP-4 inhibitors and GLP-1 agonists) on cardiovascular, gastrointestinal and renal system and to detail the mechanisms underlying their action in these systems.

Timeline

Start

2013-10

Primary completion

2015-10

Completion

2016-09

Drugs

Indications